Page last updated: 2024-08-23

vindesine and Lymphoma, T-Cell

vindesine has been researched along with Lymphoma, T-Cell in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coiffier, B; Reyes, F	1
Delsol, G; Farcet, JP; Gaulard, P; Martin-Garcia, N; Mempel, M; Rigal-Huguet, F; Suarez, F; Wlodarska, I	1
Berger, F; Brousse, N; Bryon, PA; Coiffier, B; Diebold, J; Gisselbrecht, C; Peuchmaur, M	1

Reviews

1 review(s) available for vindesine and Lymphoma, T-Cell

Article	Year
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective. Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:4 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine	2005

Trials

1 trial(s) available for vindesine and Lymphoma, T-Cell

Article	Year
Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives). Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Immunophenotyping; Lymphoma, B-Cell; Lymphoma, T-Cell; Prednisolone; Prognosis; Prospective Studies; Vindesine	1990

Article

Year

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Immunophenotyping; Lymphoma, B-Cell; Lymphoma, T-Cell; Prednisolone; Prognosis; Prospective Studies; Vindesine

1990

Other Studies

1 other study(ies) available for vindesine and Lymphoma, T-Cell

Article	Year
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. The American journal of surgical pathology, 2000, Volume: 24, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 7; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Isochromosomes; Liver Neoplasms; Lymphoma, T-Cell; Male; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Splenic Neoplasms; T-Lymphocytes; Vindesine	2000

Article

Year

Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.

The American journal of surgical pathology, 2000, Volume: 24, Issue:7

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 7; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Isochromosomes; Liver Neoplasms; Lymphoma, T-Cell; Male; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Splenic Neoplasms; T-Lymphocytes; Vindesine

2000